Cargando…
Perna canaliculus Lipid Complex PCSO-524™ Demonstrated Pain Relief for Osteoarthritis Patients Benchmarked against Fish Oil, a Randomized Trial, without Placebo Control
Osteoarthritis (OA) typically generates pain, reduced mobility and reduced quality of life. Most conventional treatments for osteoarthritis, such as non-steroidal anti-inflammatory drugs (NSAIDs) and simple analgesics, have side effects. PCSO-524™, a non polar lipid extract from the New Zealand Gree...
Autores principales: | Zawadzki, Marek, Janosch, Claudia, Szechinski, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721214/ https://www.ncbi.nlm.nih.gov/pubmed/23739042 http://dx.doi.org/10.3390/md11061920 |
Ejemplares similares
-
The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
por: SHEI, REN-JAY, et al.
Publicado: (2018) -
Perna canaliculus and the Intestinal Microbiome
por: Saltzman, Emma Tali, et al.
Publicado: (2017) -
The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2019) -
Detailed Distribution of Lipids in Greenshell™ Mussel (Perna canaliculus)
por: Miller, Matthew R., et al.
Publicado: (2014) -
The effects PCSO-524®, a patented marine oil lipid and omega-3 PUFA blend derived from the New Zealand green lipped mussel (Perna canaliculus), on indirect markers of muscle damage and inflammation after muscle damaging exercise in untrained men: a randomized, placebo controlled trial
por: Mickleborough, Timothy D, et al.
Publicado: (2015)